HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Junchang Cui Selected Research

Junchang Cui Research Topics

Disease

8Infections
01/2021 - 12/2006
3Pneumonia (Pneumonitis)
12/2021 - 01/2014
2Healthcare-Associated Pneumonia
01/2018 - 01/2015
2Bacterial Infections (Bacterial Infection)
12/2016 - 01/2015
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2017
1Sepsis (Septicemia)
12/2016
1Inflammation (Inflammations)
01/2015
1Chronic Obstructive Pulmonary Disease (COPD)
01/2015
1Invasive Pulmonary Aspergillosis
01/2014
1Neutropenia
01/2014
1Nephrotic Syndrome (Syndrome, Nephrotic)
01/2013
1Tuberculosis (Tuberculoses)
12/2005

Drug/Important Bio-Agent (IBA)

7Tigecycline (Tygacil)FDA Link
01/2018 - 01/2014
3Minocycline (Cyclops)FDA LinkGeneric
01/2018 - 01/2015
3Levofloxacin (Levaquin)FDA Link
01/2016 - 12/2006
2ceftazidime drug combination avibactamIBA
12/2021 - 01/2021
2carbapenemaseIBA
12/2021 - 01/2018
2Anti-Bacterial Agents (Antibiotics)IBA
03/2016 - 01/2015
2Moxifloxacin (Avelox)FDA Link
01/2016 - 01/2015
1Carbapenems (Carbapenem Antibiotics)IBA
01/2021
1Colistin (Coly-Mycin)FDA Link
05/2017
1Amikacin (A.M.K)FDA LinkGeneric
01/2017
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2017
1Ciprofloxacin (Cipro)FDA LinkGeneric
01/2017
1Biomarkers (Surrogate Marker)IBA
12/2016
1Urokinase Plasminogen Activator ReceptorsIBA
12/2016
1Anti-Infective Agents (Microbicides)IBA
03/2016
1Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric
01/2016
1Ticarcillin (Tarcil)FDA Link
01/2016
1Polymyxins (Polymyxin)IBA
03/2015
1Azithromycin (Zithromax)FDA LinkGeneric
01/2015
1Erythromycin (Erycette)FDA LinkGeneric
01/2015
1MacrolidesIBA
01/2015
1Omeprazole (Prilosec)FDA LinkGeneric
01/2014
1Lansoprazole (Prevacid)FDA LinkGeneric
01/2014
1AntigensIBA
01/2014
1galactomannanIBA
01/2014
1Pantoprazole (Protonix)FDA LinkGeneric
01/2014
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2013
1Pharmaceutical PreparationsIBA
12/2006
1Rifampin (Rifampicin)FDA LinkGeneric
12/2005

Therapy/Procedure

6Therapeutics
05/2017 - 12/2005
1Culture Diffusion Chambers
01/2021